UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045553
Receipt number R000051824
Scientific Title cost-effectiveness analysis of lidocaine patch for the preparation of arterial cannulation followed by cardio-vascular catheterization procedures
Date of disclosure of the study information 2021/09/23
Last modified on 2024/01/13 09:54:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

cost-effectiveness analysis of lidocaine patch for the preparation of arterial cannulation followed by cardio-vascular catheterization procedures

Acronym

cost-effectiveness of patch anesthesia for cardiovascular catheterization

Scientific Title

cost-effectiveness analysis of lidocaine patch for the preparation of arterial cannulation followed by cardio-vascular catheterization procedures

Scientific Title:Acronym

cost-effectiveness of patch anesthesia for cardiovascular catheterization

Region

Japan


Condition

Condition

ischemic heart disease, valvular heart disease, peripheral arterial disease

Classification by specialty

Medicine in general Cardiology Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the pains and the cost-effectiveness, (1) during needle puncture for anesthesia just before arterial cannulation, (2) during catheterization procedures, (3) during hemostasis time after catheterization procedure by visual analog scale between lidocaine patch anesthesia group and placebo patch group for the preparation of arterial cannulation followed by cardio-vascular catheterization

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

"pain evaluated by visual analog scale (minimum 0 cm to maximum 10 cm) and cost effectiveness analysis by incremental cost effectiveness ratio.
Pains were evaluated 3 points as below, (1) during needle puncture for anesthesia just before arterial cannulation, (2) during catheterization procedures, (3) during hemostasis time after catheterization procedure"

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

intervention group, lidocaine patch local anesthesia

Interventions/Control_2

placebo group, patch tape without drugs

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

All patients undergoing cardio-vascular catheterization at our hospital (Tsukazaki Hospital) were selected as following criteria;

signed written informed consent
age between 20 and 100-years-old
both diagnostic and therapeutic procedures



Key exclusion criteria

lacking for the understanding of visual analog scale questionnaire, both transiently and permanently

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Hagikura
Middle name
Last name Arata

Organization

Tsukazaki Hospital

Division name

department of cardiology

Zip code

6711227

Address

68-1, Waku, Aboshi-ku, Himeji, Hyogo

TEL

+81-79-272-8555

Email

hagikuraarata@hotmail.co.jp


Public contact

Name of contact person

1st name Hagikura
Middle name
Last name Arata

Organization

Tsukazaki Hospital

Division name

department of cardiology

Zip code

6711227

Address

68-1, Waku, Aboshi-ku, Himeji, Hyogo

TEL

+81-79-272-8555

Homepage URL


Email

hagikuraarata@hotmail.co.jp


Sponsor or person

Institute

department of cardiology, Tsukazaki Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee, Tsukazaki Hospital

Address

68-1

Tel

+81-79-272-8555

Email

medsafe@tsukazaki-hp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 15 Day

Date of IRB

2021 Year 08 Month 17 Day

Anticipated trial start date

2021 Year 09 Month 15 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 09 Month 23 Day

Last modified on

2024 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051824


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name